Fungal Infections and Antifungal Agents
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 18
Special Issue Editor
Interests: public health; veterinary mycology; zoonosis; sporotrichosis; antifungal therapy; antifungal resistance; natural products; antimicrobial susceptibility testing
Special Issue Information
Dear Colleagues,
Fungal infections represent a growing concern in both human and veterinary medicine, affecting a wide range of hosts and resulting in significant morbidity and mortality. The emergence of resistant strains, coupled with the limited number of effective antifungal agents, underscores the urgent need for new diagnostic and therapeutic approaches. This Special Issue aims to bring together high-quality research, case reports, and reviews that address the epidemiology, pathogenesis, diagnosis, and treatment of fungal infections across different species, including humans. We encourage the submission of works that investigate host–pathogen interactions, resistance mechanisms, the discovery of new antifungal drugs, and innovative therapeutic strategies, such as natural products, drug combinations, and nanotechnology-based systems. Contributions that integrate findings between human and animal health, from a One Health perspective, are particularly welcome. By integrating clinical, laboratory, and field data, this Special Issue seeks to foster a comprehensive understanding of fungal diseases and promote the development of more effective antifungal interventions.
Dr. Stefanie Bressan Waller
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- fungal infections
- antifungal agents
- antifungal drug discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
